SACK1A and breast cancer: Depletion of FAM83A by shRNA in malignant HMT3522 T4-2 HMECs and the breast cancer cell line MDA-MB-468 led to reduced invasiveness, proliferation rate, clonogenic potential, and tumor volume in immunocompromised mice.